An incurable disease
A new book explains how health care can become both more expensive and more affordable
HEALTH-CARE expenditure in America is growing at a disturbing rate: in 1960 it was just over 5% of GDP, in 2011 almost 18%. By 2105 the number could reach 60%, according to William Baumol of New York University’s Stern School of Business. Incredible? It is simply the result of extrapolating the impact of a phenomenon Mr Baumol has become famous for identifying: “cost disease”. His new book* gives a nuanced diagnosis, offerings both a vision of a high-cost future and a large dose of optimism. The cost disease may be incurable, but it is also survivable—if treated correctly.
This article appeared in the Finance & economics section of the print edition under the headline “An incurable disease”
More from Finance & economics
![](https://www.economist.com/cdn-cgi/image/width=1424,quality=80,format=auto/content-assets/images/20240914_FNP501.jpg)
Can anything spark Europe’s economy back to life?
Mario Draghi, the continent’s unofficial chief technocrat, has a plan
![](https://www.economist.com/cdn-cgi/image/width=1424,quality=80,format=auto/content-assets/images/20240907_FND003.jpg)
Has social media broken the stockmarket?
That is the contention of Cliff Asness, one of the great quant investors
![](https://www.economist.com/cdn-cgi/image/width=1424,quality=80,format=auto/content-assets/images/20240907_FNP504.jpg)
American office delinquencies are shooting up
How worried should investors be?
China is suffering from a crisis of confidence
Can anything perk up its economy?
America has a huge deficit. Which candidate would make it worse?
Enough policies have been proposed to make a call
Why Oasis fans should welcome price-gouging
There are worse things in life than paying a fair price